When administered to diet induced obese (DIO) mice, SR9238 (i.p.)drove a decrease in expression of Fasn, Srebf1c, and Scd1, which was associated with a significant reduction in hepatic steatosis (76). The gene discussed is FASN; the disease is fatty liver disease.